Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...
On that note, let's dive in and investigate how the bull thesis for buying Vertex stock just got even stronger. Vertex's push ...
On Wednesday, Vertex Pharmaceuticals Incorporated (VRTX) stock saw a decline, ending the day at $470.05 which represents a decrease of $-4.86 or -1.02% from the prior close of $474.91. The stock ...
Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in ...
The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and ...
A 12-year-old boy has become the first patient in the U.S. to receive gene therapy for sickle cell disease, The New York Times reported Oct ...
Boston has become world-famous for its booming biotech industry. Over the past 20 years, the city has been buzzing with groundbreaking discoveries, cutting-edge research, and influential biotech ...
Zacks.com on MSN2d
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to KnowVertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...
Vertex Pharmaceuticals dominates the cystic fibrosis market with a promising pipeline and strategic M&A activity. Read why I ...
New data released by Merck suggests AstraZeneca and Sanofi’s Beyfortus, the monoclonal antibody injection that protects ...
Vertex Pharmaceuticals VRTX has outperformed the market over the past 5 years by 6.32% on an annualized basis producing an ...
Governor Maura Healey on Tuesday announced $21.4 million in tax incentives for life sciences companies that are expected to create 1,155 jobs in the state.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback